Search results
I lost 42 pounds with Ozempic, but was shaken by the drug's psychological toll
TODAY via Yahoo News· 2 days agoEditor's note: The U.S. Food and Drug Administration label for Ozempic states that in...
Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short
BioPharma Dive via Yahoo Finance· 5 days agoBelharra will use its chemoproteomics technology to identify immune drugs for Sanofi. Elsewhere,...
Shannen Doherty hasn't 'had work since 2022' and details cancer treatment in court docs
TODAY via Yahoo News· 1 day agoShannen Doherty's cancer, stage 4, has been progressing. She has shared health updates along the...
Groundbreaking cancer treatment may trigger more cancer – but here’s why you shouldn’t worry
The Conversation· 3 days agoIn the last few decades, scientists have finally learned to harness the immune system to successfully treat cancer. Car-T therapy, short for “chimeric antigen receptor T-cell ...
US FDA puts partial clinical hold on BioNTech's early-stage study of cancer drug
Reuters· 6 days ago, opens new tab on Monday the U.S. Food and Drug Administration has placed a partial clinical hold...
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
The New York Times via Yahoo News· 2 days agoAmericans are paying too much for prescription drugs. It is a common, long-standing complaint. And...
He handed a doctor a check for $25K for cancer research. Now a new drug honors his late daughter.
NewsWatch 12 Medford - Klamath Falls· 3 days agoAs we prepare for the 18th Annual Alex's Lemonade: A Stand for Hope Telethon, we have the story of a...
Lung Cancer Drug Elicits Unprecedented Results in New Trial
GoodNewsNetwork· 4 days agoWith lung cancer being the leading cause of cancer-related deaths worldwide, news of the unprecedented success of a new drug ...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 20 hours agoIt expects to grow in all areas of its business (including oncology, cardiovascular, respiratory, and immunology) and aims to have 20 new medicines...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoAnd, last month, Pfizer unveiled positive results from a lung cancer study. The company tested its ...